COVID-19 Vaccine Myocarditis: Cautious Reassurance in an Era of Dynamic Uncertainty

J Am Coll Cardiol. 2022 Dec 13;80(24):2266-2268. doi: 10.1016/j.jacc.2022.10.010.

Authors

Peter P Liu¹, Tahir S Kafil²

Affiliations

¹ University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: peter.liu@utoronto.ca.
² University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.

No abstract available

Keywords: COVID-19; SARS-CoV-2; mRNA vaccine; myocarditis; pericarditis; prognosis; vaccination.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Myocarditis* / chemically induced

Substances

COVID-19 Vaccines

Grants and funding

CIHR/Canada